BGM Group Ltd. BGM
NASDAQ BGM
$7.90 -1.10 (-12.22%)
As of: Oct 23, 2026 · 3:41 PM EDT

Bgm (BGM) Revenue (2024 - 2025)

Updated

Bgm's Revenue was $37.92 million in FY2025 (year ended Sep 30, 2025), up 468.6% from $6.67 million in FY2024.

Analysis

Bgm (BGM) Revenue (2024 - 2025) Analysis & Trends

From FY2018 onward, Bgm has reported Revenue for 8 fiscal years.

  • Revenue shows a five-year compound annual growth rate of -5.4% (FY2020 to FY2025).
  • Annual Revenue has moved between $6.67 million (FY2024) and $64.86 million (FY2022) over five years.
  • Per Business Quant data, Revenue in earlier fiscal years was $6.67 million in FY2024 (-85.6%), $46.47 million in FY2023 (-28.3%), $64.86 million in FY2022 (+13.6%) and $57.1 million in FY2021 (+14.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 25.40 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 16.99 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 15.03 Bn
10 Bgm 29.83 Mn -25.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 37.62 Mn
Sep 30, 2024 25.80 Mn
API Access

Bgm Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=BGM&period=max&api_key=YOUR_API_KEY